BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2969)

  • 1. [Lipoprotein X in hepatobiliary diseases].
    Mordasini RC; Berthold S; Schlumpf E; Keller H; Riva G
    Schweiz Med Wochenschr; 1975 Jul; 105(27):863-72. PubMed ID: 2969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the quantitative assay of lipoprotein X in the differential diagnosis of extraphepatic obstructive jaundice and intrahepatic diseases.
    Magnani HN; Alaupovic P
    Gastroenterology; 1976 Jul; 71(1):87-93. PubMed ID: 179911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The significance of lipoprotein X in the diagnosis of obstructive jaundice: comparison with other biochemical tests (author's transl)].
    Mayr K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2193-7. PubMed ID: 240665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic efficacy of serum alkaline phosphatase and gamma-glutamyltransferase in dogs with histologically confirmed hepatobiliary disease: 270 cases (1980-1990).
    Center SA; Slater MR; Manwarren T; Prymak K
    J Am Vet Med Assoc; 1992 Oct; 201(8):1258-64. PubMed ID: 1358870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of congestive enzymes in liver and biliary tract diseases].
    Peters JE; Otto L; Gründig CA; Nilius R; Zipprich B; Eismann R; Busse HJ; Thulin H; Müller G
    Z Gesamte Inn Med; 1973 Sep; 28(18):Suppl:273-6. PubMed ID: 4148804
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of serum lipoproteid-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases.
    Milewski B; Palynyczko Z
    Pol Med Sci Hist Bull (1973); 1975; 15(5-6):551-5. PubMed ID: 1228704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic importance of lipoprotein-X (LP-X) in the diagnosis of cholestasis.
    Palynyczko Z; Milewski B
    Mater Med Pol; 1975; 7(4):327-33. PubMed ID: 175222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease.
    Ritland S
    Scand J Gastroenterol; 1975; 10(1):5-15. PubMed ID: 164686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Abnormal lipoprotein (LP-X) in the first months of life with particular reference to obstructive jaundice (author's transl)].
    Lachmann D
    Wien Klin Wochenschr Suppl; 1977; 69():3-28. PubMed ID: 266315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LP-X in the first month of life (author's transl)].
    Lachmann D; Eder G
    Padiatr Padol; 1977; 12(4):334-8. PubMed ID: 904943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic importance of low-density lipoprotein (LP-X) for the diagnosis of cholestasis].
    Michel B; Ritter U
    Z Gastroenterol; 1976 Sep; 14(5):556-64. PubMed ID: 184610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [LP-X in newborns: increased incidence of positive tests without cholestasis (author's transl)].
    Witt I; Ober M
    J Clin Chem Clin Biochem; 1976 Apr; 14(4):197-202. PubMed ID: 5573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in hepatobiliary enzymes and its isoenzymes in intrahepatic cholestasis in pregnancy].
    Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):82-5, 123-4. PubMed ID: 1677617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum 5-nucleotidase activity in chronic hepatobiliary diseases].
    Dinkov L; Kraĭnikova M; Brailski Kh
    Vutr Boles; 1979; 18(1):39-46. PubMed ID: 34931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein-X and other tests in the diagnosis of obstructive jaundice in the infant.
    Lipsitz PJ; Yoss B; Schussheim A
    Am J Gastroenterol; 1979 Jan; 71(1):95-100. PubMed ID: 86296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determination of serum lipoprotein-X (LP-X) and gamma-glutamyl transpeptidase (gamma GT); its use in the differential diagnosis of hepatobiliary diseases].
    Alegre B; Martínez M; Bretó M; García AM; Cabades F; Berenguer J
    Rev Esp Enferm Apar Dig; 1977 Jun; 50(6):641-6. PubMed ID: 19816
    [No Abstract]   [Full Text] [Related]  

  • 18. [The diagnosis of cholestasis: lipoprotein X (LP-X) (author's transl)].
    Fischer M; Falkensammer C; Barouch G; Wuketich S; Kromberger O; Schnack H
    Wien Klin Wochenschr; 1975 Sep; 87(16):524-31. PubMed ID: 5812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative changes of serum lipoprotein-X after cholestyramine administration in infants with cholestatic biliary tract and liver disease.
    Poley JR; Caplan DB; Magnani HN; Alaupovic P; Smith EI; Campbell DP; Bhatia M; Burdelski M; Bojanovski D
    Eur J Clin Invest; 1978 Dec; 8(6):397-404. PubMed ID: 105912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The angiotensinase activity of -L-asparaginyl aminopeptidase in the serum of normal subjects, in patients with hepatobiliary diseases and during pregnancy].
    Kaulhausen H; Pfeiffer P; Breuer H
    Z Klin Chem Klin Biochem; 1972 Feb; 10(2):51-5. PubMed ID: 4347073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.